ArticleFrontiers in bioengineering and biotechnology2026
Proteomic analysis of bioprinted pancreatic tumor models under different nutrient conditions.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense stromal microenvironment that restricts nutrient availability and contributes to tumor adaptation. Cancer-associated fibroblasts (CAFs), extracellular matrix components, and tumor cells participate in reciprocal interactions that influence the metabolic state of PDAC tumors. Objective: This study investigated nutrient-associated proteomic changes in three-dimensional (3D) bioprinted PDAC-CAF tumor constructs and examined alterations in metabolic and cell-junction-related pathways under nutrient-avid and nutrient-deprived conditions. Methods: Three-dimensional bioprinted pancreatic tumor constructs composed primarily of PANC1 cells and cancer-associated fibroblasts (CAFs) were cultured under nutrient-avid (N) and nutrient-deprived (N-) conditions. Constructs were monitored at Days 0, 6, and 12, and Day 6 was selected for comparative proteomic analysis as an intermediate stage at which nutrient-associated structural divergence was evident while both tumor and stromal compartments remained detectable. Label-free high-resolution LC-MS/MS proteomic profiling was followed by KEGG pathway enrichment and complementary bioinformatic analyses. Selected junction-associated findings were further examined by quantitative real-time PCR. Results: Distinct nutrient-associated proteomic signatures were observed in the bioprinted tumor constructs. Nutrient-avid conditions were associated with enrichment of pathways including pantothenate and CoA biosynthesis, β-alanine metabolism, and arginine and proline metabolism. Nutrient-deprived conditions showed enrichment of pathways related to unsaturated fatty-acid biosynthesis, fatty-acid elongation, riboflavin metabolism, folate-associated metabolism, and terpenoid backbone biosynthesis. Nutrient-associated differences were also observed among proteins assigned to gap-junction, adherens-junction, focal-adhesion, tight-junction, and central-carbon-metabolism pathways. Selected junction-associated proteomic observations were supported at the transcript level by qPCR, although concordance between mRNA and protein abundance varied among targets. Conclusion: Nutrient availability was associated with distinct metabolic and junction-related proteomic signatures in 3D bioprinted PDAC-CAF constructs. These findings provide hypothesis-generating evidence of nutrient-dependent molecular remodeling within a multicellular PDAC model. Functional perturbation studies will be required to determine the causal and therapeutic relevance of the candidate proteins and pathways identified here.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.